Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: WESTLAW - Investors want more frequent company meeting
1
Sep 22, 2011 02:14PM

< Corporations, on the other hand, often argue that special meetings are costly, time-consuming, and empower large minority shareholders at the expense of other shareholders.>

I didn't see anything in there which might refute that statement. Corrections welcomed.

Opty

Share
New Message
Please login to post a reply